US Stock MarketDetailed Quotes

KALV KalVista Pharmaceuticals

Watchlist

14.470
-0.920-5.98%

Close Jul 24 16:00 ET

14.470
0.0000.00%

Post 16:02 ET

618.38MMarket Cap-4206P/E (TTM)

KalVista Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

(Q1)Jul 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-18.56%-89.23M

33.27%-15.11M

-196.81%-27.57M

3.73%-19.83M

-17.54%-26.73M

3.68%-75.26M

15.50%-22.64M

33.96%-9.29M

-5.37%-20.59M

-28.23%-22.74M

Net income from continuing operations

-36.31%-126.64M

-69.74%-44.65M

-36.26%-29.03M

-24.23%-27.65M

-9.87%-25.32M

-12.83%-92.91M

-9.09%-26.31M

5.19%-21.3M

-13.27%-22.26M

-43.04%-23.04M

Operating gains losses

61.80%-565K

86.16%-31K

27.45%-436K

155.75%611K

-260.41%-709K

-169.34%-1.48M

-119.67%-224K

-198.85%-601K

-414.04%-1.1M

1,094.59%442K

Depreciation and amortization

13.65%816K

16.49%219K

4.02%207K

13.87%197K

22.15%193K

27.30%718K

20.51%188K

33.56%199K

36.22%173K

19.70%158K

Other non cash items

-114.29%-12K

-103.13%-1K

-80.00%2K

-200.00%-19K

-73.91%6K

-53.07%84K

23.08%32K

-90.65%10K

-20.83%19K

4.55%23K

Change In working capital

104.60%15.17M

1,364.73%16.61M

-110.47%-1.03M

1,784.96%3.81M

-25.72%-4.22M

160.16%7.41M

115.89%1.13M

140.22%9.86M

94.24%-226K

37.45%-3.36M

-Change in receivables

453.02%8.18M

429.69%14.39M

-122.93%-2.11M

43.23%-2.03M

41.62%-2.08M

55.47%-2.32M

-17.21%-4.37M

59.06%9.19M

11.73%-3.57M

-11.18%-3.57M

-Change in prepaid assets

-108.04%-538K

-164.18%-1.44M

-81.65%145K

2.86%1.76M

-151.83%-1M

172.09%6.69M

140.03%2.25M

163.71%790K

195.60%1.72M

409.60%1.94M

-Change in payables and accrued expense

147.75%7.53M

12.74%3.66M

907.83%929K

150.25%4.07M

34.22%-1.13M

40.76%3.04M

47.01%3.25M

73.26%-115K

-14.78%1.63M

-12.56%-1.72M

Cash from discontinued investing activities

Operating cash flow

-18.56%-89.23M

33.27%-15.11M

-196.81%-27.57M

3.73%-19.83M

-17.54%-26.73M

3.68%-75.26M

15.50%-22.64M

33.96%-9.29M

-5.37%-20.59M

-28.23%-22.74M

Investing cash flow

Cash flow from continuing investing activities

-304.56%-84.72M

-1,931.98%-126.19M

-166.27%-6.7M

42.08%28.56M

-34.72%19.61M

-28.42%41.42M

-149.94%-6.21M

-119.51%-2.52M

13.91%20.1M

101.90%30.04M

Capital expenditure reported

---401K

----

--0

----

Net PPE purchase and sale

96.49%-42K

78.26%-15K

-26.67%-19K

98.96%-2K

99.35%-6K

-28.46%-1.2M

19.77%-69K

92.57%-15K

46.07%-192K

-220.56%-920K

Net intangibles purchase and sale

----

---91K

----

--0

----

Net investment purchase and sale

-297.78%-84.28M

-1,952.83%-126.06M

-163.47%-6.59M

41.75%28.76M

-36.64%19.62M

-27.52%42.61M

-149.05%-6.14M

-119.09%-2.5M

12.73%20.29M

104.14%30.96M

Cash from discontinued investing activities

Investing cash flow

-304.56%-84.72M

-1,931.98%-126.19M

-166.27%-6.7M

42.08%28.56M

-34.72%19.61M

-28.42%41.42M

-149.94%-6.21M

-119.51%-2.52M

13.91%20.1M

101.90%30.04M

Financing cash flow

Cash flow from continuing financing activities

159.33%150.71M

454,942.42%150.1M

-99.51%284K

-23.81%128K

21.43%204K

3,575.90%58.12M

-123.91%-33K

7,388.73%57.81M

166.67%168K

-72.37%168K

Net common stock issuance

71.34%96.95M

--96.95M

----

--56.58M

--0

----

Proceeds from stock option exercised by employees

3,405.15%53.77M

161,169.70%53.15M

-76.93%284K

-23.81%128K

21.43%204K

-2.97%1.53M

-123.91%-33K

59.46%1.23M

166.67%168K

-72.37%168K

Cash from discontinued financing activities

Financing cash flow

159.33%150.71M

454,942.42%150.1M

-99.51%284K

-23.81%128K

21.43%204K

3,575.90%58.12M

-123.91%-33K

7,388.73%57.81M

166.67%168K

-72.37%168K

Net cash flow

Beginning cash position

82.99%56.24M

-72.89%23.06M

49.45%57.67M

30.49%49.41M

82.99%56.24M

-39.26%30.73M

86.61%85.05M

-17.01%38.59M

-21.68%37.86M

-39.26%30.73M

Current changes in cash

-195.74%-23.24M

130.50%8.81M

-173.88%-33.99M

2,800.91%8.86M

-192.54%-6.91M

229.83%24.27M

-103.13%-28.88M

11,866.50%46.01M

82.16%-328K

432.59%7.47M

Effect of exchange rate changes

-198.14%-1.21M

-208.82%-74K

-235.89%-621K

-157.33%-602K

124.78%84K

205.91%1.24M

110.83%68K

187.38%457K

8,176.92%1.05M

-11,200.00%-339K

End cash Position

-43.47%31.79M

-72.89%23.06M

49.45%57.67M

30.49%49.41M

82.99%56.24M

86.61%85.05M

-17.01%38.59M

-21.68%37.86M

Free cash flow

-17.29%-89.67M

32.94%-15.23M

-197.52%-27.68M

3.64%-20.03M

-12.99%-26.74M

3.30%-76.46M

15.52%-22.71M

34.79%-9.3M

-4.45%-20.79M

-31.30%-23.66M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022	(Q1)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-18.56%-89.23M	33.27%-15.11M	-196.81%-27.57M	3.73%-19.83M	-17.54%-26.73M	3.68%-75.26M	15.50%-22.64M	33.96%-9.29M	-5.37%-20.59M	-28.23%-22.74M
Net income from continuing operations	-36.31%-126.64M	-69.74%-44.65M	-36.26%-29.03M	-24.23%-27.65M	-9.87%-25.32M	-12.83%-92.91M	-9.09%-26.31M	5.19%-21.3M	-13.27%-22.26M	-43.04%-23.04M
Operating gains losses	61.80%-565K	86.16%-31K	27.45%-436K	155.75%611K	-260.41%-709K	-169.34%-1.48M	-119.67%-224K	-198.85%-601K	-414.04%-1.1M	1,094.59%442K
Depreciation and amortization	13.65%816K	16.49%219K	4.02%207K	13.87%197K	22.15%193K	27.30%718K	20.51%188K	33.56%199K	36.22%173K	19.70%158K
Other non cash items	-114.29%-12K	-103.13%-1K	-80.00%2K	-200.00%-19K	-73.91%6K	-53.07%84K	23.08%32K	-90.65%10K	-20.83%19K	4.55%23K
Change In working capital	104.60%15.17M	1,364.73%16.61M	-110.47%-1.03M	1,784.96%3.81M	-25.72%-4.22M	160.16%7.41M	115.89%1.13M	140.22%9.86M	94.24%-226K	37.45%-3.36M
-Change in receivables	453.02%8.18M	429.69%14.39M	-122.93%-2.11M	43.23%-2.03M	41.62%-2.08M	55.47%-2.32M	-17.21%-4.37M	59.06%9.19M	11.73%-3.57M	-11.18%-3.57M
-Change in prepaid assets	-108.04%-538K	-164.18%-1.44M	-81.65%145K	2.86%1.76M	-151.83%-1M	172.09%6.69M	140.03%2.25M	163.71%790K	195.60%1.72M	409.60%1.94M
-Change in payables and accrued expense	147.75%7.53M	12.74%3.66M	907.83%929K	150.25%4.07M	34.22%-1.13M	40.76%3.04M	47.01%3.25M	73.26%-115K	-14.78%1.63M	-12.56%-1.72M
Cash from discontinued investing activities
Operating cash flow	-18.56%-89.23M	33.27%-15.11M	-196.81%-27.57M	3.73%-19.83M	-17.54%-26.73M	3.68%-75.26M	15.50%-22.64M	33.96%-9.29M	-5.37%-20.59M	-28.23%-22.74M
Investing cash flow
Cash flow from continuing investing activities	-304.56%-84.72M	-1,931.98%-126.19M	-166.27%-6.7M	42.08%28.56M	-34.72%19.61M	-28.42%41.42M	-149.94%-6.21M	-119.51%-2.52M	13.91%20.1M	101.90%30.04M
Capital expenditure reported	---401K	----	----	----	----	--0	----	----	----	----
Net PPE purchase and sale	96.49%-42K	78.26%-15K	-26.67%-19K	98.96%-2K	99.35%-6K	-28.46%-1.2M	19.77%-69K	92.57%-15K	46.07%-192K	-220.56%-920K
Net intangibles purchase and sale	----	----	---91K	----	----	----	----	--0	----	----
Net investment purchase and sale	-297.78%-84.28M	-1,952.83%-126.06M	-163.47%-6.59M	41.75%28.76M	-36.64%19.62M	-27.52%42.61M	-149.05%-6.14M	-119.09%-2.5M	12.73%20.29M	104.14%30.96M
Cash from discontinued investing activities
Investing cash flow	-304.56%-84.72M	-1,931.98%-126.19M	-166.27%-6.7M	42.08%28.56M	-34.72%19.61M	-28.42%41.42M	-149.94%-6.21M	-119.51%-2.52M	13.91%20.1M	101.90%30.04M
Financing cash flow
Cash flow from continuing financing activities	159.33%150.71M	454,942.42%150.1M	-99.51%284K	-23.81%128K	21.43%204K	3,575.90%58.12M	-123.91%-33K	7,388.73%57.81M	166.67%168K	-72.37%168K
Net common stock issuance	71.34%96.95M	--96.95M	----	----	----	--56.58M	--0	----	----	----
Proceeds from stock option exercised by employees	3,405.15%53.77M	161,169.70%53.15M	-76.93%284K	-23.81%128K	21.43%204K	-2.97%1.53M	-123.91%-33K	59.46%1.23M	166.67%168K	-72.37%168K
Cash from discontinued financing activities
Financing cash flow	159.33%150.71M	454,942.42%150.1M	-99.51%284K	-23.81%128K	21.43%204K	3,575.90%58.12M	-123.91%-33K	7,388.73%57.81M	166.67%168K	-72.37%168K
Net cash flow
Beginning cash position	82.99%56.24M	-72.89%23.06M	49.45%57.67M	30.49%49.41M	82.99%56.24M	-39.26%30.73M	86.61%85.05M	-17.01%38.59M	-21.68%37.86M	-39.26%30.73M
Current changes in cash	-195.74%-23.24M	130.50%8.81M	-173.88%-33.99M	2,800.91%8.86M	-192.54%-6.91M	229.83%24.27M	-103.13%-28.88M	11,866.50%46.01M	82.16%-328K	432.59%7.47M
Effect of exchange rate changes	-198.14%-1.21M	-208.82%-74K	-235.89%-621K	-157.33%-602K	124.78%84K	205.91%1.24M	110.83%68K	187.38%457K	8,176.92%1.05M	-11,200.00%-339K
End cash Position	-43.47%31.79M	-43.47%31.79M	-72.89%23.06M	49.45%57.67M	30.49%49.41M	82.99%56.24M	82.99%56.24M	86.61%85.05M	-17.01%38.59M	-21.68%37.86M
Free cash flow	-17.29%-89.67M	32.94%-15.23M	-197.52%-27.68M	3.64%-20.03M	-12.99%-26.74M	3.30%-76.46M	15.52%-22.71M	34.79%-9.3M	-4.45%-20.79M	-31.30%-23.66M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall